Literature DB >> 20860890

Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases.

G G Kovacs1, H Budka.   

Abstract

Definitive diagnosis of neurodegenerative diseases (NDDs) relies on the neuropathological evaluation. NDDs are defined as disorders with progressive loss of neurons showing distinct anatomical distribution, and accordingly different clinical phenotypes. Recent research has identified a spectrum of immunohistochemically detectable proteins deposited in the central nervous system which serve as a basis for protein-based disease classification. Accordingly, diagnostic criteria and disease staging have been updated. Furthermore, it has become evident that there is considerable overlap between deposited proteins and pathologies. This review summarizes recent achievements in neuropathological diagnosis and classification of NDDs and recommends approaches to be used during the diagnostic procedure in practice, thus to serve as guideline for a common level of diagnostic quality.

Entities:  

Mesh:

Year:  2010        PMID: 20860890     DOI: 10.5414/npp29271

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  11 in total

1.  Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease.

Authors:  Istvan Kapas; Katalin Majtenyi; Klara Törö; Eva Keller; Till Voigtländer; Gabor G Kovacs
Journal:  Metab Brain Dis       Date:  2012-04-27       Impact factor: 3.584

2.  Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up.

Authors:  Magdalena Bruzova; Robert Rusina; Zuzana Stejskalova; Radoslav Matej
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

3.  Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.

Authors:  Sally Hunter; Thais Minett; Tuomo Polvikoski; Elizabeta Mukaetova-Ladinska; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2015-08-28       Impact factor: 6.982

Review 4.  Clinical neuropathology practice guide 5-2013: markers of neuronal maturation.

Authors:  Harvey B Sarnat
Journal:  Clin Neuropathol       Date:  2013 Sep-Oct       Impact factor: 1.368

5.  Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease.

Authors:  Sabrina Büttner; Lukas Habernig; Filomena Broeskamp; Doris Ruli; F Nora Vögtle; Manolis Vlachos; Francesca Macchi; Victoria Küttner; Didac Carmona-Gutierrez; Tobias Eisenberg; Julia Ring; Maria Markaki; Asli Aras Taskin; Stefan Benke; Christoph Ruckenstuhl; Ralf Braun; Chris Van den Haute; Tine Bammens; Anke van der Perren; Kai-Uwe Fröhlich; Joris Winderickx; Guido Kroemer; Veerle Baekelandt; Nektarios Tavernarakis; Gabor G Kovacs; Jörn Dengjel; Chris Meisinger; Stephan J Sigrist; Frank Madeo
Journal:  EMBO J       Date:  2013-10-15       Impact factor: 11.598

6.  Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases.

Authors:  Zdenek Rohan; Magdalena Smetakova; Jaromir Kukal; Robert Rusina; Radoslav Matej
Journal:  BMC Neurol       Date:  2015-03-31       Impact factor: 2.474

7.  Prevalence of mixed pathologies in the aging brain.

Authors:  Jasmin Rahimi; Gabor G Kovacs
Journal:  Alzheimers Res Ther       Date:  2014-11-21       Impact factor: 6.982

8.  Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study.

Authors:  Ursula Unterberger; Ingolf Lachmann; Till Voigtländer; Walter Pirker; Anna S Berghoff; Katharina Flach; Uta Wagner; Aline Geneste; Armand Perret-Liaudet; Gabor G Kovacs
Journal:  Clin Neuropathol       Date:  2014 Sep-Oct       Impact factor: 1.368

Review 9.  Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.

Authors:  Gargi Ganguly; Sasanka Chakrabarti; Uttara Chatterjee; Luciano Saso
Journal:  Drug Des Devel Ther       Date:  2017-03-16       Impact factor: 4.162

Review 10.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.